8 Reasons for less weight loss with GLP1 RAs for T2D could include use of insulin or other obesity-promoting medications, concerns over hypoglycemia, decreased glycosuria, microbiome variation, genetic predisposition towards weight gain, and differences in endogenous GLP-1 pathways in the brain and other tissues
Early in life, an overabundance of axon targeting is often observed, which is then refined to match neuronal requirements specified by activity or chemical signals
Hydroxocobalamin has a higher affinity to the TC II transport protein than cyanocobalamin, or adenosylcobalamin
10.1200/jco.2008.16.3725 75 MehdiS
Caution is advised in patients with a history of pancreatitis, and these medications should be avoided during pregnancy or discontinued well before planned conception (e.g., 2 months before planned pregnancy for semaglutide based on its half-life)
If youve been anywhere near the news lately, youve probably seen some truly terrifying headlines: Some Ozempic users are developing serious eye issues that lead to blindness (New York Post) Patients on Ozempic report waking up blind in as little as a day after using jab (The Scottish Sun) People taking weight-loss drugs say they are losing their sight
